Earnings Recaps

Browse reported earnings of the most popular stocks

May 16, 2026 May 15, 2026 May 14, 2026 May 13, 2026 May 12, 2026 May 11, 2026 May 10, 2026 May 9, 2026 May 8, 2026 May 7, 2026 May 6, 2026 May 5, 2026 May 4, 2026 May 3, 2026 May 2, 2026 May 1, 2026 Apr 30, 2026 Apr 29, 2026 Apr 23, 2026 Apr 22, 2026 Apr 21, 2026 Apr 20, 2026 Apr 18, 2026 Apr 17, 2026 Apr 16, 2026 Apr 15, 2026 Apr 14, 2026 Apr 13, 2026 Apr 10, 2026 Apr 9, 2026 Apr 8, 2026 Apr 7, 2026 Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026 Jan 7, 2026 Jan 6, 2026 Dec 19, 2025 Dec 18, 2025 Dec 17, 2025 Dec 12, 2025 Dec 11, 2025 Dec 10, 2025 Dec 9, 2025 Dec 6, 2025 Dec 5, 2025 Dec 4, 2025 Dec 3, 2025 Dec 2, 2025 Dec 1, 2025 Nov 27, 2025 Nov 26, 2025 Nov 25, 2025 Nov 24, 2025 Nov 23, 2025 Nov 21, 2025 Nov 20, 2025 Nov 19, 2025 Nov 18, 2025 Nov 17, 2025 Nov 15, 2025 Nov 14, 2025 Nov 13, 2025 Nov 12, 2025 Nov 11, 2025 Nov 10, 2025 Nov 9, 2025 Nov 8, 2025 Nov 7, 2025 Nov 6, 2025 Nov 5, 2025 Nov 4, 2025 Nov 1, 2025 Oct 31, 2025 Oct 30, 2025 Oct 29, 2025 Oct 28, 2025 Oct 27, 2025 Oct 25, 2025 Oct 24, 2025 Oct 23, 2025 Oct 22, 2025 Oct 21, 2025 Oct 17, 2025 Oct 16, 2025 Oct 15, 2025 Oct 14, 2025 Oct 9, 2025 Oct 8, 2025 Oct 7, 2025 Sep 25, 2025 Sep 23, 2025 Sep 17, 2025 Sep 16, 2025 Sep 11, 2025 Sep 10, 2025 Sep 9, 2025 Sep 5, 2025 Sep 4, 2025 Sep 3, 2025
22 companies Today

AGNC Investment Corp.

AGNC Q1 2026
Reported: 2026-04-21

AGNC delivered a quarterly loss of $0.18 per share amid increased spread volatility driven by geopolitical risks, but showed signs of recovery in April with a 6% rebound in tangible book value.

Key takeaways
  • First-quarter economic return was negative 1.6%, impacted by wider mortgage spreads and market volatility.
  • Despite headwinds, Agency MBS outperformed Treasuries and investment-grade corporates, underscoring diversification benefits.
  • Spread levels improved in early 2026, with current ranges of 150–175 basis points offering attractive risk-adjusted value.
  • Supply was lower than initial expectations, with estimated MBS issuance reduced by $50–$70 billion due to higher mortgage rates.
  • Funding conditions and demand dynamics remain favorable, supported by increased institutional appetite and potential regulatory easing for mortgage credit.

Atos SE

ATO.PA Q1 2026
Reported: 2026-04-21

Atos delivered a solid Q1 2026 with improved financial stability, strong operational execution, and a focus on strategic growth pillars, setting a positive trajectory for the year.

Key takeaways
  • Revenue reached EUR 1.7 billion, driven by core perimeter improvement and ongoing asset sales, with cash flow benefiting from EUR 71 million restructuring proceeds.
  • Book-to-bill ratio hit a 5-year high at 89%, reflecting solid order momentum, particularly in North America, despite some top-line pressure.
  • Strategic initiatives under the Genesis plan are advancing ahead of schedule, with EUR 650 million in savings nearly achieved and extended to 2026, supporting margin expansion.
  • Headcount reduced to approximately 55,000 through restructuring and optimized hiring, enhancing operational efficiency; billability rate above 80%.
  • Focused on AI, Sovereign, and Cyber, with new manifestos launched, reinforcing Atos’ positioning as a cybersecurity leader in Europe amidst a cautiously optimistic outlook.

Beiersdorf Aktiengesellschaft

BEI.DE Q1 2026
Reported: 2026-04-21

NIVEA experienced a challenging Q1 with a 7% decline amid market headwinds, but strategic rebalancing initiatives show early signs of restoring growth, supported by strong derma performance and targeted portfolio adjustments.

Key takeaways
  • Group organic net sales declined 4.6%, with NIVEA dropping 7%, primarily due to market conditions, lapping prior-year peaks, and temporary disruptions.
  • Derma outperformed with 8.2% organic growth, led by innovations like Thiamidol and successful expansions in North America, Brazil, and China.
  • La Prairie faced headwinds from U.S. department store and travel retail disruptions, resulting in a 14.9% decline, though retail demand remains positive.
  • NIVEA's rebalancing focuses on expanding face, body, and deodorant categories, with early market share gains in emerging markets and Europe.
  • Innovation remains a pillar, with NIVEA Epicelline on track, showing promising repurchase trends aligned with Eucerin’s success.

Community

See what investors are trading, holding, and sharing

🌐
All
📈
Stock
📊
ETF
🏦
Mutual Fund
🪙
Crypto
💱
Forex
# Asset Price Community % Type Currency Sector
Loading...